A new era has dawned in the world of cannabis research. After becoming only, the second country in the world to legalize cannabis Canada is now in an ideal position to establish cross country research programs into the world of cannabinoids. The cannabis plant is a cornucopia of chemicals with a very wide range of […]

Influenza causes seasonal illness characterized by fever, myalgia and respiratory symptoms which can lead to hospitalization and death. Although it is a vaccine preventable disease, influenza contributes directly and indirectly to a large number of hospitalizations and outpatient visits. More specifically, influenza causes every year approximately 12,000 hospitalizations and 3,500 deaths in Canada, of which […]

The long term objective of this project is to develop methods of revegetating mine tailings sites (in this case, a very large tailing mound in northern Quebec) using natural vegetation, and without transporting soil long distances. The specific objective of this project over the next year is to (i) conduct field trials to determine the […]

The development of cellular therapeutics is acutely dependent on the ability to evaluate the functional characteristics of the cells in predictive animal models. This forms the basis of key pre-clinical data packages that are key for regulatory submissions preceding human clinical trials. The development of appropriate model systems, the execution of the surgical techniques to […]

Copper has long been proposed to have important biological properties. Designed to deliver the health benefits of copper, CuTEC yarn is a USPTO|EPO patent pending, bio-engineered copper-based yarn that can be produced as products such as clothing and mattress ticking. Although many believe in the positive properties of copper for well-being, many remain retiscent to […]

It remains unclear if fishes that occupy Canada’s leading tidal energy test site in Minas Passage, Bay of Fundy, Nova Scotia, will be negatively affected by turbine installations. The objective of this project is to determine fishes’ interactions with operating turbines. Of approximately 70 species of fishes that interact with Minas Passage only three have […]

Invasive aquatic species are one of the largest threats to aquatic ecosystems and cost Canadians around $343 million annually. Aquatic invasive species negatively impacts recreational use of freshwater and can decrease water quality, reduce native populations, and can cause fisheries to collapse. Prussian carp are an invasive species native to Asia that have recently been […]

Mite and insect pests pose an ongoing threat to the sustainability of greenhouse vegetable production. Their control is critically reliant on pesticides. However, the intensive use of pesticides and the shrinking number of registered insecticides and acaricides increases the selection pressure against the few chemicals available and accelerates the evolution of resistance. This is critical […]

Revegetation of northern Manitoba ecosystems, disturbed by hydroelectric development, is critical to meet the ecological and cultural needs of the First Nation communities located in these areas. To establish a viable self-sustaining ecosystem, it is important to understand the challenges associated with reclamation in these disturbed areas. The main goal of our proposed research is […]

Leukemia, lymphoma and other forms of blood cancers are still largely diagnosed every year in Canada. These diseases constitute the second leading cause of cancer related death in young adults and the sixth in adult. The five-year survival rates still range between 42% and 85%. Currently, the main treatment is a stem cell transplantation which […]

Long dsRNA is produced by viruses during their replicative cycle. In plants and invertebrates, long dsRNAs block crucial cellular processes through RNA interference (RNAi). In vertebrates, long dsRNA is a potent inducer of critical signaling proteins that regulate antiviral immune responses. Although the RNAi system is conserved in vertebrates, there is little evidence to suggest […]

Twenty years ago, the first human genome was sequenced at a cost of 3 billion dollars. Today, this can be done in a day at a cost of approximately $1000. Despite this drastic reduction, the promise of personalized medicine, to customize therapy for each patient, has not yet been realized through next generation sequencing (NGS). […]